PULM Stock Analysis: Buy, Sell, or Hold?
PULM - Pulmatrix, Inc. Common Stock
$1.58
0.08 (5.69%)
▲
5d:
+1.28%
30d:
-10.73%
90d:
+15.33%
BUY
MODERATE Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Oct 15, 2026
Get Alerted When PULM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PULM shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: PULM shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PULM is currently trading at $1.58, which is considered slightly low relative to its 30-day fair value range of $1.55 to $1.71.
Technical Outlook: Technically, PULM is in a strong uptrend. Immediate support is located at $1.45, while resistance sits at $1.68. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: PULM scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.00 (+566.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PULM is in a strong uptrend. Immediate support is located at $1.45, while resistance sits at $1.68. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: PULM scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.00 (+566.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.55 -
$1.71
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.7%)
- BULLISH: Trading 566.7% below Wall St target ($10.00)
- BULLISH: Bottoming setup score 60/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.55 -
$1.71
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.45
Resistance Level
$1.68
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Wall Street Target
$10.00
(+566.7%)
Revenue Growth (YoY)
-99.9%
Share & Embed Analysis
Last updated: August 24, 2026 2:08 PM ET
Data refreshes hourly during market hours. Next update: 3:08 PM
Data refreshes hourly during market hours. Next update: 3:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PULM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 39 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 46 HOLD |
